Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients

Oncology Reports

Volumn 25, Issue 4, 2011, Pages 1063-1071

  Kwon, Youngmee ^a   Ro, Jungsil ^a   Kang, Han Sung ^a   Kim, Seok Ki ^a   Hong, Eun Kyung ^a   Khang, Shin Kwang ^b   Gong, Gyungyub ^b   Ro, Jae Y ^c  

^a National Cancer Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Biological markers; Breast neoplasms; Sentinel lymph node biopsy; Tissue array analysis

Indexed keywords

CYCLIN D1; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P21; PROTEIN P53; PROTEIN P63; UVOMORULIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SENTINEL LYMPH NODE METASTASIS; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952211805     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1157     Document Type: Article

References (52)

1. Abdessalam SF, Zervos EE, Prasad M, et al: Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182: 316-320, 2001. (Pubitemid 33079078)
2. Reynolds C, Mick R, Donohue JH, et al: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17: 1720-1726, 1999.
3. O'Hea BJ, Hill AD, El-Shirbiny AM, et al: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186: 423-427, 1998. (Pubitemid 28169364)
4. Sener SF, Winchester DJ, Martz CH, et al: Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92: 748-752, 2001. (Pubitemid 32783058)
5. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A and Giuliano AE: Do all the patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229: 536-541, 1999.
6. Degnim AC, Griffith KA, Sabel MS, et al: Clinicopathologic features of metastasis in non-sentinel lymph nodes of breast carcinoma patients. Cancer 98: 2307-2315, 2003. (Pubitemid 37466644)
7. Giuliano AE, Kirgan DM, Guenther JM and Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220: 391-401, 1994. (Pubitemid 24313232)
8. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 339: 941-946, 1998. (Pubitemid 28455095)
9. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA and Lavin PT: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131: 301-308, 1996.
10. Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM and Osborne MP: Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 191: 1-6, 2000.
11. Lindahl T, Engel G, Ahlgren J, et al: Can axillary dissection be avoided by improved molecular biological diagnosis? Acta Oncol 39: 319-326, 2000.
12. Fisher B, Redmund C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681, 1985. (Pubitemid 15134703)
13. Weaver DL, Krag DN, Ashikaga T, Harlow SP and O'Connell M: Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 88: 1099-1107, 2000. (Pubitemid 30127672)
14. Cserni G, Burzykowski T, Vinh-Hung V, et al: Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn J Clin Oncol 34: 519-524, 2004. (Pubitemid 43115281)
15. Turner RR, Chu K, Qi K, et al: Pathologic features associated with non-sentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89: 574-581, 2000. (Pubitemid 30640103)
16. Weiser MR, Montgomery LL, Tan LK, et al: Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8: 145-149, 2001. (Pubitemid 32199411)
17. Rahusen FD, Torrenga H, van Diest PJ, et al: Predictive factors for metastatic involvement of non-sentinel nodes in patients with breast cancer. Arch Surg 136: 1059-1063, 2001. (Pubitemid 32982998)
18. Wong SL, Edwards MJ, Chao C, et al: Predicting the status of the non-sentinel axillary nodes: a multicenter study. Arch Surg 136: 563-568, 2001. (Pubitemid 32417547)
19. Cserni G: Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 27: 532-538, 2001.
20. Kamath VJ, Giuliano R, Dauway EL, et al: Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 136: 688-692, 2001. (Pubitemid 32525473)
21. Canavese G, Gipponi M, Catturich A, et al: Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Oncol 77: 81-87, 2001. (Pubitemid 32520766)
22. Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ and Brower S: Predictors of non-sentinel lymph node metastasis in breast cancer patients. Am J Surg 183: 213-217, 2002. (Pubitemid 34273972)
23. Mignotte H, Treilleux I, Faure C, Nessah K and Bremond A: Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 28: 623-626, 2002.
24. Hwang RF, Krishnamurthy S, Hunt KK, et al: Clinicopathologic factors predicting involvement of non-sentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10: 248-254, 2003. (Pubitemid 40486957)
25. Van Iterson V, Leidenius M, Krogerus L and von Smitten K: Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 82: 39-45, 2003. (Pubitemid 37476018)
26. Nos C, Harding-MacKean C, Freneaux P, et al: Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 90: 1354-1360, 2003.
27. Travagli JP, Atallah D, Mathieu MC, et al: Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 29: 403-406, 2003. (Pubitemid 36675702)
28. Stitzenberg KB, Meyer AA, Stern SL, et al: Extracapsular extension of the sentinel lymph node metastasis: a predictor of non-sentinel node tumor burden. Ann Surg 237: 607-612, 2003
29. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA and Schnabel F: Predictors of non-sentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 139: 648-651, 2004. (Pubitemid 38725073)
30. Farshid G, Pradhan M, Kollias J and Gill PG: A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast 13: 494-501, 2004. (Pubitemid 39618822)
31. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE and ALMANAC Trialists Group: Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 40: 1731-1737, 2004. (Pubitemid 38902909)
32. Fleming FJ, Kavanagh D, Crotty TB, et al: Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol 57: 73-76, 2004. (Pubitemid 38091315)
33. Viale G, Maiorano E, Pruneri G, et al: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241: 319-325, 2005.
34. Hung WK, Chan MC, Mak KL, et al: Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes. ANZ J Surg 75: 27-31, 2005. (Pubitemid 40394699)
35. Callejo IP, Brito JA, Bivar JW, et al: Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transi Oncol 7: 18-22, 2005.
36. Yu JC, Hsu GC, Hsieh CB, Sheu LF and Chao TY: Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg 29: 813-818, 2005.
37. Ozmen V, Karanlik H, Cabioglu N, et al: Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 95: 1-6, 2006. (Pubitemid 43228075)
38. Bolster MJ, Peer PG, Bult P, et al: Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol 14: 181-189, 2007.
39. Kapur U, Rubinas T, Ghai R, Sinacore J, Yao K and Rajan PB: Prediction of non-sentinel lymph node metastasis in sentinel node-positive breast carcinoma. Ann Diag Pathol 11: 10-12, 2007. (Pubitemid 46107878)
40. Jinno H, Sakata M, Asaga S, et al: Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Breast J 14: 551-555, 2008.
41. Fougo JL, Afonso M, Senhoraes Senra F, et al: Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors? Clin Transi Oncol 11: 165-171, 2009.
42. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: 1140-1151, 2003. (Pubitemid 40486808)
43. Degnim AC, Reynolds C, Pantvaidya, et al: Non-sentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190: 543-550, 2005. (Pubitemid 41306072)
44. Kohrt HE, Olshen RA, Bermas, et al: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8: 66, 2008.
45. Pal A, Provenzano E, Duffy SW, Pinder SE and Purushotham AD: A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95: 302-309, 2008.
46. Cho J, Han W, Lee JW, et al: A scoring system to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring system. Ann Surg Oncol 15: 2278-2286, 2008.
47. Gur AS, Unal B, Johnson R, et al: Predictive probability of four different breast cancer nomograms for non-sentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208: 229-235, 2009.
48. Coutant C, Olivier C, Lambaudie E, et al: Comparison of models to predict non-setinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 27: 2800-2808, 2009.
49. Nielsen TO, Hsu FD, Jensen K, et al: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367-5374, 2004. (Pubitemid 39100473)
50. Han S, Park K, Bae BN, et al: Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer. J Surg Oncol 83: 241-247, 2003. (Pubitemid 36936010)
51. -/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11: 1154-1159, 2005. (Pubitemid 40175765)
52. Olson JA Jr, McCall LM, Beitsch P, et al: Impact of immediate versus delayed axillary dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Trials Z0010 and Z0011. J Clin Oncol 26: 3530-3535, 2008.